blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2618827

EP2618827 - ANTIDIABETIC SOLID PHARMACEUTICAL COMPOSITIONS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  08.04.2022
Database last updated on 19.10.2024
FormerThe patent has been granted
Status updated on  30.04.2021
FormerGrant of patent is intended
Status updated on  15.12.2020
FormerExamination is in progress
Status updated on  04.05.2018
Most recent event   Tooltip06.09.2024Lapse of the patent in a contracting state
New state(s): MT		published on 09.10.2024  [2024/41]
Applicant(s)For all designated states
Intekrin Therapeutics, Inc.
4300 El Camino Real Suite. 201
Los Altos, CA 94022 / US
[2021/22]
Former [2013/31]For all designated states
Intekrin Therapeutics, Inc.
4300 El Camino Real Suite. 201
Los Altos, CA 94022 / US
Inventor(s)01 / LEE, Kathleen, M.
4173 El Camino Real Apt. 20
Palo Alto, CA 94303 / US
02 / HIGGINS, Linda
3610 Louis Road
Palo Alto, CA 94303 / US
03 / LANFEAR, Dennis
80 Valencia Court
Portola Valley, CA 94028 / US
 [2013/31]
Representative(s)Fish & Richardson P.C.
Highlight Business Towers
Mies-van-der-Rohe-Straße 8
80807 München / DE
[2021/22]
Former [2013/31]Oldroyd, Richard Duncan, et al
Elkington and Fife LLP Prospect House 8 Pembroke Road
Sevenoaks, Kent TN13 1XR / GB
Application number, filing date11827285.519.09.2011
[2021/22]
WO2011US52100
Priority number, dateUS20100384991P21.09.2010         Original published format: US 384991 P
[2013/31]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2012040082
Date:29.03.2012
Language:EN
[2012/13]
Type: A2 Application without search report 
No.:EP2618827
Date:31.07.2013
Language:EN
The application published by WIPO in one of the EPO official languages on 29.03.2012 takes the place of the publication of the European patent application.
[2013/31]
Type: B1 Patent specification 
No.:EP2618827
Date:02.06.2021
Language:EN
[2021/22]
Search report(s)International search report - published on:KR28.06.2012
(Supplementary) European search report - dispatched on:EP26.08.2015
ClassificationIPC:A61K9/16, A61K9/20, A61K9/48, A61K31/47, A61P3/10
[2021/01]
CPC:
A61K31/47 (EP,US); A61K31/18 (EP,US); A61K9/1623 (EP,US);
A61K9/1635 (EP,US); A61K9/1652 (EP,US); A61K9/2018 (EP,US);
A61K9/2027 (EP,US); A61K9/2054 (EP,US); A61K9/4858 (EP,US);
A61K9/4866 (EP,US); A61P29/00 (EP); A61P3/00 (EP);
A61P3/10 (EP); A61P43/00 (EP); Y10T428/2982 (EP,US) (-)
Former IPC [2015/39]A61K9/16, A61K9/20, A61K9/48, A61K31/18, A61K31/47, A61P3/00, A61P3/10, A61P29/00
Former IPC [2013/31]A61K31/47, A61K31/18, A61K9/20, A61K9/16, A61K9/48, A61P3/10, A61P3/00
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2013/31]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:ANTIDIABETISCHE PHARMAZEUTISCHE FESTSTOFFZUSAMMENSETZUNGEN[2013/31]
English:ANTIDIABETIC SOLID PHARMACEUTICAL COMPOSITIONS[2013/31]
French:COMPOSITIONS PHARMACEUTIQUES SOLIDES ANTIDIABÉTIQUES[2013/31]
Entry into regional phase17.04.2013National basic fee paid 
17.04.2013Search fee paid 
17.04.2013Designation fee(s) paid 
17.04.2013Examination fee paid 
Examination procedure17.04.2013Examination requested  [2013/31]
21.03.2016Amendment by applicant (claims and/or description)
07.05.2018Despatch of a communication from the examining division (Time limit: M08)
16.01.2019Reply to a communication from the examining division
17.11.2020Cancellation of oral proceeding that was planned for 19.11.2020
19.11.2020Date of oral proceedings (cancelled)
16.12.2020Communication of intention to grant the patent
23.04.2021Fee for grant paid
23.04.2021Fee for publishing/printing paid
23.04.2021Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  07.05.2018
Opposition(s)03.03.2022No opposition filed within time limit [2022/19]
Fees paidRenewal fee
27.09.2013Renewal fee patent year 03
29.09.2014Renewal fee patent year 04
28.09.2015Renewal fee patent year 05
27.09.2016Renewal fee patent year 06
27.09.2017Renewal fee patent year 07
27.09.2018Renewal fee patent year 08
27.09.2019Renewal fee patent year 09
28.09.2020Renewal fee patent year 10
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU19.09.2011
AL02.06.2021
AT02.06.2021
CY02.06.2021
CZ02.06.2021
DK02.06.2021
EE02.06.2021
FI02.06.2021
HR02.06.2021
LT02.06.2021
LV02.06.2021
MC02.06.2021
MK02.06.2021
MT02.06.2021
NL02.06.2021
PL02.06.2021
RO02.06.2021
RS02.06.2021
SE02.06.2021
SI02.06.2021
SK02.06.2021
SM02.06.2021
BG02.09.2021
NO02.09.2021
GR03.09.2021
IE19.09.2021
LU19.09.2021
BE30.09.2021
CH30.09.2021
LI30.09.2021
IS02.10.2021
PT04.10.2021
[2024/41]
Former [2024/22]HU19.09.2011
AL02.06.2021
AT02.06.2021
CY02.06.2021
CZ02.06.2021
DK02.06.2021
EE02.06.2021
FI02.06.2021
HR02.06.2021
LT02.06.2021
LV02.06.2021
MC02.06.2021
MK02.06.2021
NL02.06.2021
PL02.06.2021
RO02.06.2021
RS02.06.2021
SE02.06.2021
SI02.06.2021
SK02.06.2021
SM02.06.2021
BG02.09.2021
NO02.09.2021
GR03.09.2021
IE19.09.2021
LU19.09.2021
BE30.09.2021
CH30.09.2021
LI30.09.2021
IS02.10.2021
PT04.10.2021
Former [2023/28]HU19.09.2011
AL02.06.2021
AT02.06.2021
CY02.06.2021
CZ02.06.2021
DK02.06.2021
EE02.06.2021
FI02.06.2021
HR02.06.2021
LT02.06.2021
LV02.06.2021
MC02.06.2021
NL02.06.2021
PL02.06.2021
RO02.06.2021
RS02.06.2021
SE02.06.2021
SI02.06.2021
SK02.06.2021
SM02.06.2021
BG02.09.2021
NO02.09.2021
GR03.09.2021
IE19.09.2021
LU19.09.2021
BE30.09.2021
CH30.09.2021
LI30.09.2021
IS02.10.2021
PT04.10.2021
Former [2023/24]AL02.06.2021
AT02.06.2021
CY02.06.2021
CZ02.06.2021
DK02.06.2021
EE02.06.2021
FI02.06.2021
HR02.06.2021
LT02.06.2021
LV02.06.2021
MC02.06.2021
NL02.06.2021
PL02.06.2021
RO02.06.2021
RS02.06.2021
SE02.06.2021
SI02.06.2021
SK02.06.2021
SM02.06.2021
BG02.09.2021
NO02.09.2021
GR03.09.2021
IE19.09.2021
LU19.09.2021
BE30.09.2021
CH30.09.2021
LI30.09.2021
IS02.10.2021
PT04.10.2021
Former [2022/37]AL02.06.2021
AT02.06.2021
CZ02.06.2021
DK02.06.2021
EE02.06.2021
FI02.06.2021
HR02.06.2021
LT02.06.2021
LV02.06.2021
MC02.06.2021
NL02.06.2021
PL02.06.2021
RO02.06.2021
RS02.06.2021
SE02.06.2021
SI02.06.2021
SK02.06.2021
SM02.06.2021
BG02.09.2021
NO02.09.2021
GR03.09.2021
IE19.09.2021
LU19.09.2021
BE30.09.2021
CH30.09.2021
LI30.09.2021
IS02.10.2021
PT04.10.2021
Former [2022/35]AL02.06.2021
AT02.06.2021
CZ02.06.2021
DK02.06.2021
EE02.06.2021
FI02.06.2021
HR02.06.2021
LT02.06.2021
LV02.06.2021
MC02.06.2021
NL02.06.2021
PL02.06.2021
RO02.06.2021
RS02.06.2021
SE02.06.2021
SI02.06.2021
SK02.06.2021
SM02.06.2021
BG02.09.2021
NO02.09.2021
GR03.09.2021
IE19.09.2021
LU19.09.2021
BE30.09.2021
IS02.10.2021
PT04.10.2021
Former [2022/34]AL02.06.2021
AT02.06.2021
CZ02.06.2021
DK02.06.2021
EE02.06.2021
FI02.06.2021
HR02.06.2021
LT02.06.2021
LV02.06.2021
MC02.06.2021
NL02.06.2021
PL02.06.2021
RO02.06.2021
RS02.06.2021
SE02.06.2021
SI02.06.2021
SK02.06.2021
SM02.06.2021
BG02.09.2021
NO02.09.2021
GR03.09.2021
LU19.09.2021
BE30.09.2021
IS02.10.2021
PT04.10.2021
Former [2022/29]AL02.06.2021
AT02.06.2021
CZ02.06.2021
DK02.06.2021
EE02.06.2021
FI02.06.2021
HR02.06.2021
LT02.06.2021
LV02.06.2021
MC02.06.2021
NL02.06.2021
PL02.06.2021
RO02.06.2021
RS02.06.2021
SE02.06.2021
SI02.06.2021
SK02.06.2021
SM02.06.2021
BG02.09.2021
NO02.09.2021
GR03.09.2021
IS02.10.2021
PT04.10.2021
Former [2022/25]AL02.06.2021
AT02.06.2021
CZ02.06.2021
DK02.06.2021
EE02.06.2021
FI02.06.2021
HR02.06.2021
LT02.06.2021
LV02.06.2021
MC02.06.2021
NL02.06.2021
PL02.06.2021
RO02.06.2021
RS02.06.2021
SE02.06.2021
SK02.06.2021
SM02.06.2021
BG02.09.2021
NO02.09.2021
GR03.09.2021
IS02.10.2021
PT04.10.2021
Former [2022/21]AT02.06.2021
CZ02.06.2021
DK02.06.2021
EE02.06.2021
FI02.06.2021
HR02.06.2021
LT02.06.2021
LV02.06.2021
NL02.06.2021
PL02.06.2021
RO02.06.2021
RS02.06.2021
SE02.06.2021
SK02.06.2021
SM02.06.2021
BG02.09.2021
NO02.09.2021
GR03.09.2021
IS02.10.2021
PT04.10.2021
Former [2022/10]AT02.06.2021
CZ02.06.2021
EE02.06.2021
FI02.06.2021
HR02.06.2021
LT02.06.2021
LV02.06.2021
NL02.06.2021
PL02.06.2021
RO02.06.2021
RS02.06.2021
SE02.06.2021
SK02.06.2021
SM02.06.2021
BG02.09.2021
NO02.09.2021
GR03.09.2021
IS02.10.2021
PT04.10.2021
Former [2022/09]AT02.06.2021
CZ02.06.2021
FI02.06.2021
HR02.06.2021
LT02.06.2021
LV02.06.2021
NL02.06.2021
PL02.06.2021
RO02.06.2021
RS02.06.2021
SE02.06.2021
SK02.06.2021
SM02.06.2021
BG02.09.2021
NO02.09.2021
GR03.09.2021
PT04.10.2021
Former [2022/07]AT02.06.2021
FI02.06.2021
HR02.06.2021
LT02.06.2021
LV02.06.2021
NL02.06.2021
PL02.06.2021
RS02.06.2021
SE02.06.2021
SM02.06.2021
BG02.09.2021
NO02.09.2021
GR03.09.2021
Former [2021/52]FI02.06.2021
HR02.06.2021
LT02.06.2021
LV02.06.2021
PL02.06.2021
RS02.06.2021
SE02.06.2021
BG02.09.2021
NO02.09.2021
GR03.09.2021
Former [2021/51]FI02.06.2021
HR02.06.2021
LT02.06.2021
LV02.06.2021
RS02.06.2021
SE02.06.2021
BG02.09.2021
NO02.09.2021
GR03.09.2021
Former [2021/49]FI02.06.2021
HR02.06.2021
LT02.06.2021
LV02.06.2021
SE02.06.2021
BG02.09.2021
NO02.09.2021
GR03.09.2021
Former [2021/47]FI02.06.2021
LT02.06.2021
BG02.09.2021
Former [2021/46]FI02.06.2021
LT02.06.2021
Documents cited:Search[XI]EP1905450  (DAIICHI SANKYO CO LTD [JP]) [X] 1-5,9-13,15 * page 2, paragraph 1 * * page 2, paragraph 7 - page 5, paragraph 8 * * page 5, paragraphs 12-14 * [I] 6-8,14;
 [XI]US2006223870  (DOKEN KAZUHIRO [JP], et al) [X] 1,3-5,9-13,15 * page 1, paragraphs 1,17-24 * * page 2, paragraph 50 * * page 3, paragraph 58 * * page 3, paragraph 67 - page 4, paragraph 83 * * page 5, paragraphs 92,93 * [I] 2,6-8,14;
 [XI]WO2007072992  (TAKEDA PHARMACEUTICAL [JP], et al) [X] 1,3-5,9-13,15 * page 1, lines 5-8 * * page 4, line 23 - page 7, line 7 * * page 9, lines 4-16 * * page 21, line 17 - page 27, line 25 * * page 34, lines 2-16 * * page 37, line 24 - page 39, line 17 * [I] 2,6-8,14;
 [XI]EP1738754  (TAKEDA PHARMACEUTICAL [JP]) [X] 1,3-6,9-13,15 * column 1, paragraph 1 * * column 2, paragraph 6 - column 3, paragraph 9 * * column 4, paragraph 18 - column 5, paragraph 22 * * column 14, paragraphs 92,93 * * column 14, paragraph 95 - column 15, paragraph 96 * [I] 2,7,8,14;
 [XI]WO2006044391  (INTERCEPT PHARMACEUTICALS INC [US], et al) [X] 1,3,4,15 * page 3, paragraph 11 - page 4, paragraph 11 * * page 18, paragraph 67 - page 19, paragraph 68 * * claims 1,9,10 * [I] 2,5-14;
 [XP]WO2011017488  (INTEKRIN THERAPEUTICS INC [US], et al) [XP] 1-4,15 * page 1, paragraph 1 * * page 4, paragraphs 12,15 * * page 19, paragraph 72 - page 20, paragraph 73 * * page 26, paragraph 99 - page 27, paragraph 100 * * page 30, paragraphs 111,112 *
International search[X]US2002169185  (MCGEE LAWRENCE R [US], et al);
 [X]US2003139390  (MCGEE LAWRENCE R [US], et al);
 [X]US2007293536  (KRUK HENRY T [US], et al);
 [X]WO2009111078  (INTEKRIN THERAPEUTICS INC [US], et al);
 [X]US2010087481  (LEE KATHLEEN M [US])
by applicantWO0100579
 US6200995
 US6583157
 US6653332
 US7041691
 EP1738754
 US7223761
 US2007293536
 WO2010040055
 US19580611026
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.